The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

Stock Information

 

Share information:

The company is listed on Nasdaq First North Sweden with expected first day of trading
June 24, 2021 with the ticker name BIOSGN (ISIN code SE0016013460).
The Company’s nominal share capital is DKK 702,544  divided into shares of SEK 0.025.
The total number of shares is 28,101,775. Each individual share entitles one vote in the
company and has equal rights to the company’s assets and profits.


Investor warrants

Investor warrants TO1
The warrants of series TO1 will be issued under ISIN code SE0016013478.
The investor warrants of series “Biosergen TO1″ is traded on Nasdaq First North Growth
Market under the ticker “BIOSGN TO1“.
The total number of warrants within the series is 5,000,000.
The warrants may be utilized for subscription of shares from May 30, 2022 up to, and
including, June 10, 2022.
Each warrant entitles the holder to subscribe for one (1) new share in the Company.